Correlation Between Zambal Spain and Vytrus Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zambal Spain and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zambal Spain and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zambal Spain Socimi and Vytrus Biotech SA, you can compare the effects of market volatilities on Zambal Spain and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zambal Spain with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zambal Spain and Vytrus Biotech.

Diversification Opportunities for Zambal Spain and Vytrus Biotech

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zambal and Vytrus is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Zambal Spain Socimi and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Zambal Spain is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zambal Spain Socimi are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Zambal Spain i.e., Zambal Spain and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Zambal Spain and Vytrus Biotech

Assuming the 90 days trading horizon Zambal Spain Socimi is expected to generate 0.49 times more return on investment than Vytrus Biotech. However, Zambal Spain Socimi is 2.04 times less risky than Vytrus Biotech. It trades about -0.1 of its potential returns per unit of risk. Vytrus Biotech SA is currently generating about -0.08 per unit of risk. If you would invest  115.00  in Zambal Spain Socimi on September 3, 2024 and sell it today you would lose (21.00) from holding Zambal Spain Socimi or give up 18.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.68%
ValuesDaily Returns

Zambal Spain Socimi  vs.  Vytrus Biotech SA

 Performance 
       Timeline  
Zambal Spain Socimi 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zambal Spain Socimi has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Vytrus Biotech SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Zambal Spain and Vytrus Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zambal Spain and Vytrus Biotech

The main advantage of trading using opposite Zambal Spain and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zambal Spain position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.
The idea behind Zambal Spain Socimi and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities